Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

By sjmartinez • November 3, 2022

Weitz JI, Szekanecz Z, Charles-Schoeman C, Vranic I, Sahin B, Paciga SA, Wang Z, Hyde C, Martin DA. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 Nov;8(2):e002571. doi: 10.1136/rmdopen-2022-002571. PMID: 36323490.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, Publications, Rheumatoid, Rheumatology

Assessment of Seroprevalence and Neutralizing Antibodies for Healthcare Worker Protection in a Crimean-Congo Hemorrhagic Fever Endemic Area

Pınarlık F, Karaşahin Ö, Yanık A, Akça D, Sarıkaya Rİ, Güllü D, Arslan EN, Yalçın S, Barlas T, Can FK, Alay H, Özden K, Kuşkucu[...]

Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies

Tajdini M, Tavakoli K, Jenkin SC, Keykhaei M, Hahn VS. Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies.[...]

Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022)

Masias K, Tejada A, Segura ER, Ormea V. Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022). N Z Vet[...]